PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Cardiovascular Science Program-ICCC, IR-Hospital de la Santa Creu i Santa Pau, Ciber CV, Autonomous University of Barcelona, Barcelona, Spain.\', \'Department of Cardiology, School for Cardiovascular Diseases, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands.\', \'Division of Cardiology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.\', \'Cardiovascular Research Unit, Department of Population Health, Luxembourg Institute of Health, 1A-B rue Edison, L-1445 Strassen, Luxembourg.\', \'Department of Molecular Genetics, Faculty of Science and Engineering, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands.\', \'National Heart & Lung Institute, Faculty of Medicine, Imperial College London, London, UK.\', \'Cardiometabolic Research Group and MTA-SE System Pharmacology Research Group, Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest,Hungary.\', \'Pharmahungary Group, Szeged, Hungary.\', \'Luxembourg Center for Systems Biomedicine, University of Luxembourg, Esch sur Alzette, Luxembourg.\', \'Department of Cardiology, Medical University of Vienna, Vienna, Austria.\', \'TAmiRNA GmbH, Vienna, Austria.\', \'Faculty of Engineering and Natural Sciences, International University of Sarajevo, Sarajevo, Bosnia and Herzegovina.\', \'Department of Intelligent Systems, Jozef Stefan Institute, Ljubljana, Slovenia.\', \'Molecular Cardiology Laboratory, IRCCS Policlinico San Donato, San Donato Milanese, Milan 20097, Italy.\', \'University of Zagreb School of Medicine, Zagreb, Croatia.\', \'Institute for Clinical Medical Research and Education, University Hospital Centre Sisters of Charity, Zagreb, Croatia.\', \'Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover,Germany.\', \'REBIRTH Center for Translational Regenerative Medicine, Hannover Medical School, Hannover, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/cvr/cvab094
?:doi
?:hasPublicationType
?:journal
  • Cardiovascular research
is ?:pmid of
?:pmid
?:pmid
  • 33839767
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 3.002
?:rankingScore_hIndex
  • 195
is ?:relation_isRelatedTo_publication of
?:title
  • Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33839767>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33839767>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all